Fundz

Virpax Pharmaceuticals Appoints Usama Chaudhry as Chief Financial Officer

PRIVATENov 20, 2024

Position

Chief Financial Officer

Company

Virpax Pharmaceuticals

Usama Chaudhry
BerwynBiotechnologyHealth CareTherapeuticsPharmaceutical

Description

Virpax Pharmaceuticals has appointed Usama Chaudhry as Chief Financial Officer, bringing his expertise in corporate development and financial strategy to the company. With a strong background in investor relations and corporate governance, Chaudhry is expected to enhance financial reporting and strategic alignment at Virpax.

Other recent leadership changes in Therapeutics and Pharmaceutical

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Virpax Pharmaceuticals, and when

A new leader at Virpax Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Virpax Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Virpax Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Virpax Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Virpax Pharmaceuticals

Location

Berwyn, Pennsylvania, United States

About

Virpax is pioneering advanced healthcare solutions with Probudur, its flagship product leveraging proprietary liposomal encapsulation. Designed for sustained release, Probudur delivers local anesthetic at the wound/incision site, effectively managing post-operative pain for an extended 96 hours. Collaborating through Cooperative Research and Development Agreements (CRADA) and partnering with prestigious institutions like the National Institute of Health/NCATS and U.S. Army Institute of Surgical Research/Department of Defense, we are committed to developing non-addictive treatments. Additionally, our involvement in the Epilepsy Therapy Screening Program (ETSP) underscores our dedication to addressing drug-resistant epilepsy and rare diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Virpax Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Gerald W.
Likely contact at this company
••••••••@••••••••

See Gerald W.'s verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Virpax Pharmaceuticals's next move

Learn about Strategic plan

Virpax Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.